Enbrel* Improved Some Measures of Quality of Life and Skin Symptoms in Patients with Psoriasis as Early as One Week

New data presented at the American Academy of Dermatology annual meeting, held over the weekend in New Orleans, Louisiana, showed that at three months, nearly 30% of psoriasis patients taking Enbrel* (etanercept) in a phase III clinical trial reported that they were "not at all" bothered by their psoriasis... click link for more info.

Continue to Enbrel* Improved Some Measures of Quality of Life and Skin Symptoms in Patients with Psoriasis as Early as One Week on Medical News Today.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz